Atlas Trials

A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

Clinical trial NCT03384420 · COMPLETED

Trial details

NCT number
NCT03384420
Sponsor
Minovia Therapeutics Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mitochondrial DiseasesPearson Syndrome
Start date
2019-02-13
Primary completion
2021-03-09
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.